Who is sponsoring NCT05398978?

NCT05398978 is sponsored by North South University.

What drugs are being tested in NCT05398978?

Interventions in NCT05398978: e-Registration and mHealth.

What condition does NCT05398978 study?

NCT05398978 studies Place of Delivery.

Is NCT05398978 still recruiting?

NCT05398978 is currently status unknown. Last updated 1 June 2022.

Last reviewed 2022-06-01 · How we verify

NCT05398978

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of e-Registration and mHealth on Institutional Deliveries in the Hazard-prone Areas

Status unknown NA Last updated 1 June 2022

What this trial tests

NA trial testing e-Registration and mHealth in Place of Delivery in 536 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
30 November 2022

30 November 2022

Quick facts

Lead sponsor	North South University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	536
Start date	1 June 2022
Primary completion	30 November 2022
Estimated completion	30 November 2022

Drugs / interventions tested

e-Registration and mHealth

Conditions studied

Place of Delivery — all drugs for Place of Delivery →

Sponsor

North South University

Who can join

Adults 19 to 45, female only, with Place of Delivery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to determine the effect of the eRegistration tracking system and mHealth counseling on institutional deliveries to pregnant mothers in the hazard-prone areas of Southern Bangladesh.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Evaluating the impact of e-registration and mHealth on institutional delivery in hazard-prone areas of Bangladesh: A protocol for a non-randomized controlled cluster trial.
Chowdhury AT, Jabeen S, Sultana ZZ, Rahman AE, et al · · 2023 · PMID 37756321 · DOI 10.1371/journal.pone.0271364
Evaluating the impact of e-registration and mHealth on institutional delivery in hazard-prone areas of Bangladesh: A protocol for a non-randomized controlled cluster trial
Chowdhury AT, Jabeen S, Sultana ZZ, Rahman AE, et al · · 2022 · DOI 10.1101/2022.06.30.22277099

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05398978 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by North South University
Last refreshed: 1 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05398978.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing